Adverse pregnancy outcomes are associated with shorter telomere length in the 17-year-old child.


Journal

Journal of developmental origins of health and disease
ISSN: 2040-1752
Titre abrégé: J Dev Orig Health Dis
Pays: England
ID NLM: 101517692

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

This study examined associations between pregnancy and infant birth outcomes with child telomere length at age 17 years; and investigated if there are sex differences between pregnancy complications and telomere length. We utilised the population-based prospective Raine cohort study in Western Australia, Australia. 2900 pregnant women were recruited at 16-20 weeks' gestation (Gen 1), and their children (Gen 2) were followed up over several years. Generalised linear models were used to examine relationships between pregnancy or birth outcomes (gestational diabetes, pre-eclampsia, preterm birth, low birth weight, macrosomia), and as a composite, with telomere length, measured via a DNA sample from blood at 17 years of age. Analyses were adjusted for a range of confounders. Among the 1202 included children, there were no differences in child telomere length for any of the individual maternal or birth weight pregnancy outcomes nor were there any significant interactions between each of the complications (individual or composite) and the sex of the child. However, females born from any of the 5 adverse outcomes had shorter telomeres (estimated mean (SE) = -0.159 (0.061),

Identifiants

pubmed: 39474905
pii: S2040174424000291
doi: 10.1017/S2040174424000291
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26

Auteurs

Tina Bianco-Miotto (T)

School of Agriculture, Food and Wine, & Waite Research Institute, University of Adelaide, SA, Australia.
Robinson Research Institute, University of Adelaide, SA, Australia.

Aaron L Phillips (AL)

School of Agriculture, Food and Wine, & Waite Research Institute, University of Adelaide, SA, Australia.

Dale R Heinze (DR)

Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, SA, Australia.

Craig E Pennell (CE)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, The University of Newcastle, Australia.

Richard K Maganga (RK)

Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, WA, Australia.

Lawrence J Beilin (LJ)

Medical School, Royal Perth Unit, The University of Western Australia, WA, Australia.

Trevor A Mori (TA)

Medical School, Royal Perth Unit, The University of Western Australia, WA, Australia.

Jessica A Grieger (JA)

Robinson Research Institute, University of Adelaide, SA, Australia.
Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH